Additionally, another study involving 335 unselected stage I-IIIA NSCLC patients described the relationship between the Ang-2 expression and survival; illuminated Ang-4 and Ang-2 were independently associated with survival, and the expression of VEGF was strongly associated with that of Ang-2 [22]. The gene discussed is ANGPT2; the disease is non-small cell lung carcinoma.